Definitions of reflux disease and its separation from dyspepsia

Management strategies for reflux disease are very different from those for dyspepsia and so differentiating between patients with “true” dyspepsia and those whose primary symptom is heartburn is a key step in their management. This separation has become more clear during the last decade as insights into reflux disease and dyspepsia have improved. It is likely that the use of short self administered questionnaires in routine clinical care will improve the reliability of separation of reflux induced symptoms from true dyspepsia.

[1]  A. Blum,et al.  Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification , 1999, Gut.

[2]  P J Kahrilas,et al.  An evidence-based appraisal of reflux disease management — the Genval Workshop Report , 1998, Gut.

[3]  I. Wiklund,et al.  Gastro‐oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole , 1998 .

[4]  K. Lauritsen Management of endoscopy‐negative reflux disease: progress with short‐term treatment , 1997 .

[5]  A. Smout Evaluation and significance of reflux from the duodenum and stomach , 1997 .

[6]  A. Smout,et al.  Endoscopy‐negative acid reflux disease , 1997 .

[7]  L. Lundell,et al.  Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. , 1997, Scandinavian journal of gastroenterology.

[8]  J. Galmiche,et al.  Treating the symptoms of gastro‐oesophageal reflux disease: a double‐blind comparison of omeprazole and cisapride , 1997, Alimentary pharmacology & therapeutics.

[9]  R. Hunt,et al.  Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. , 1997, Gastroenterology.

[10]  A R Zinsmeister,et al.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. , 1997, Gastroenterology.

[11]  J R Bennett,et al.  The endoscopic assessment of esophagitis: a progress report on observer agreement. , 1996, Gastroenterology.

[12]  F. Campbell,et al.  Importance of reflux symptoms in functional dyspepsia. , 1995, Gut.

[13]  T. Havelund,et al.  Interobserver variation in the endoscopic diagnosis of reflux esophagitis. , 1993, Scandinavian journal of gastroenterology.

[14]  F. Johnsson,et al.  Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire , 1993, Alimentary pharmacology & therapeutics.

[15]  E. Hewson,et al.  Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain. , 1991, The American journal of medicine.

[16]  A. Klauser,et al.  Symptoms in gastro-oesophageal reflux disease , 1990, The Lancet.

[17]  F. Johnsson,et al.  Reproducibility of ambulatory oesophageal pH monitoring. , 1988, Gut.

[18]  A. Oluwasanmi,et al.  Gastro-oesophageal reflux disease. , 1999, Hospital medicine.

[19]  J. Dent,et al.  The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. , 1998, Scandinavian journal of gastroenterology.

[20]  T. Venables,et al.  Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. , 1997, Scandinavian journal of gastroenterology.

[21]  A. Hungin,et al.  Gastro-oesophageal reflux disease in primary care in Europe: Clinical presentation and endoscopic findings , 1995 .